LATEST NEWS | Facebook's Zuckerberg to keep iron grip after IPO | SAN FRANCISCO (Reuters) - Facebook unveiled plans for the biggest ever Internet IPO that could raise as much as $10 billion, but made it clear CEO Mark Zuckerberg will exercise almost complete control over the company, leaving investors with little say. | Full Article | | Glencore and Xstrata in $80 billion merger talks | February 02, 2012 08:28 AM ET | LONDON (Reuters) - Mining group Xstrata and commodities trader Glencore are in talks over an all-share merger that could create a combined group worth more than 50 billion pounds ($79 billion), shaking up the industry with its biggest deal to date. | Full Article | Sony sees $2.9 billion loss, new CEO warns of pain | February 02, 2012 08:18 AM ET | TOKYO (Reuters) - Ailing Japanese electronics giant Sony Corp warned it was heading for a bigger-than-expected $2.9 billion annual loss, presenting a daunting task for incoming CEO Kazuo Hirai, who vowed to move quickly to turn things around. | Full Article | Deutsche Bank's Ackermann era ends in quarterly loss | February 02, 2012 06:29 AM ET | FRANKFURT (Reuters) - Josef Ackermann's reign at Deutsche Bank ended in a surprise quarterly loss on Thursday, with the bank hit by a downturn in bond trading due to the euro zone crisis and writedowns on holdings in drug and gambling companies. | Full Article | | | BUSINESS NEWS | Europe gets bond market respite, real economy pain | February 02, 2012 09:30 AM ET | MADRID/FRANKFURT (Reuters) - Spain and France gained fresh relief at bond auctions on Thursday, extending a rally in euro zone government debt markets since the European Central Bank flooded banks with cheap money in December. | Full Article | Merck profit beats as research trimmed | February 02, 2012 08:48 AM ET | (Reuters) - Merck & Co on Thursday reported better-than-expected fourth-quarter earnings, helped by a decrease in research spending, and predicted relatively flat 2012 results as the No. 2 U.S. drugmaker girds for cheaper generic forms of its biggest product, asthma drug Singulair. | Full Article | Dow Chemical profit misses | February 02, 2012 08:20 AM ET | (Reuters) - Dow Chemical Co's quarterly profit and revenue missed Wall Street's expectations as demand for electronics, plastics and coatings plunged, causing the company to cut production and aggressively conserve cash. | Full Article | Costco, Limited impress in January | February 02, 2012 08:36 AM ET | (Reuters) - A handful of U.S. retailers, including Costco Wholesale Corp and Limited Brands Inc , beat Wall Street's expectations for January sales, but analysts are not so optimistic about department store chains and apparel chains that have yet to report on Thursday. | Full Article | | | HEALTH NEWS | | | | RELATED VIDEO | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today. | | Your daily briefing on the latest tech developments from around the world from Reuters expert tech correspondents. Register Today. | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day.. Register Today. | | » MORE NEWSLETTERS | | ODDLY ENOUGH | | | |
No comments:
Post a Comment